BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35489437)

  • 21. Lamina Propria CD4+LAP+ Regulatory T Cells Are Increased in Active Ulcerative Colitis but Show Increased IL-17 Expression and Reduced Suppressor Activity.
    D'Ambrosio A; Cossu A; Amendola A; Zandri A; Butera A; Sanchez M; Biffoni M; Pronio A; Montesani C; Kohn A; Pica R; Boirivant M
    J Crohns Colitis; 2016 Mar; 10(3):346-53. PubMed ID: 26589955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease.
    Molnár K; Vannay A; Szebeni B; Bánki NF; Sziksz E; Cseh A; Győrffy H; Lakatos PL; Papp M; Arató A; Veres G
    World J Gastroenterol; 2012 Jul; 18(25):3254-9. PubMed ID: 22783049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells.
    Beswick EJ; Johnson JR; Saada JI; Humen M; House J; Dann S; Qiu S; Brasier AR; Powell DW; Reyes VE; Pinchuk IV
    J Immunol; 2014 Sep; 193(5):2218-29. PubMed ID: 25070848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease.
    Saito S; Tsuno NH; Sunami E; Hori N; Kitayama J; Kazama S; Okaji Y; Kawai K; Kanazawa T; Watanabe T; Shibata Y; Nagawa H
    J Gastroenterol; 2003; 38(3):229-37. PubMed ID: 12673445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined Positive Score for Programmed Death Ligand-1 Expression and Inflammatory Microenvironment in Gastrointestinal Stromal Tumors.
    Herlea V; Roșulescu A; Calotă VC; Croitoru V; Stoica Mustafa E; Vasilescu C; Alexandrescu S; Dumitrașcu T; Popescu I; Dima SO; Sajin M
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208498
    [No Abstract]   [Full Text] [Related]  

  • 27. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.
    Bruno ME; Rogier EW; Arsenescu RI; Flomenhoft DR; Kurkjian CJ; Ellis GI; Kaetzel CS
    Dig Dis Sci; 2015 Oct; 60(10):2976-84. PubMed ID: 25956706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated miRNA Inversely Correlates with
    Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K
    Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease.
    Nielsen OH; Kirman I; Rüdiger N; Hendel J; Vainer B
    Scand J Gastroenterol; 2003 Feb; 38(2):180-5. PubMed ID: 12678335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal alpha-defensin expression in pediatric inflammatory bowel disease.
    Zilbauer M; Jenke A; Wenzel G; Goedde D; Postberg J; Phillips AD; Lucas M; Noble-Jamieson G; Torrente F; Salvestrini C; Heuschkel R; Wirth S
    Inflamm Bowel Dis; 2011 Oct; 17(10):2076-86. PubMed ID: 21910169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-Cell Analyses of Colon and Blood Reveal Distinct Immune Cell Signatures of Ulcerative Colitis and Crohn's Disease.
    Mitsialis V; Wall S; Liu P; Ordovas-Montanes J; Parmet T; Vukovic M; Spencer D; Field M; McCourt C; Toothaker J; Bousvaros A; ; ; Shalek AK; Kean L; Horwitz B; Goldsmith J; Tseng G; Snapper SB; Konnikova L
    Gastroenterology; 2020 Aug; 159(2):591-608.e10. PubMed ID: 32428507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
    Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
    J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer.
    Imai D; Yoshizumi T; Okano S; Uchiyama H; Ikegami T; Harimoto N; Itoh S; Soejima Y; Aishima S; Oda Y; Maehara Y
    Cancer Med; 2017 Jul; 6(7):1614-1626. PubMed ID: 28602029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression.
    Xu SM; Shi CJ; Xia RH; Wang LZ; Tian Z; Ye WM; Liu L; Liu SL; Zhang CY; Hu YH; Zhou R; Han Y; Wang Y; Zhang ZY; Li J
    Front Immunol; 2021; 12():798424. PubMed ID: 35145511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Could the PD-1 Pathway Be a Potential Target for Treating Small Intestinal Adenocarcinoma?
    Thota R; Gonzalez RS; Berlin J; Cardin DB; Shi C
    Am J Clin Pathol; 2017 Sep; 148(3):208-214. PubMed ID: 28821192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matrix metalloproteinases cleave membrane-bound PD-L1 on CD90+ (myo-)fibroblasts in Crohn's disease and regulate Th1/Th17 cell responses.
    Aguirre JE; Beswick EJ; Grim C; Uribe G; Tafoya M; Chacon Palma G; Samedi V; McKee R; Villeger R; Fofanov Y; Cong Y; Yochum G; Koltun W; Powell D; Pinchuk IV
    Int Immunol; 2020 Jan; 32(1):57-68. PubMed ID: 31633754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of microRNA-155 in inflammatory bowel disease and its clinical significance].
    Ye YL; Pang Z; Gu W; Zheng JJ
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(47):3716-3719. PubMed ID: 29325325
    [No Abstract]   [Full Text] [Related]  

  • 40. DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.
    Howell KJ; Kraiczy J; Nayak KM; Gasparetto M; Ross A; Lee C; Mak TN; Koo BK; Kumar N; Lawley T; Sinha A; Rosenstiel P; Heuschkel R; Stegle O; Zilbauer M
    Gastroenterology; 2018 Feb; 154(3):585-598. PubMed ID: 29031501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.